KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

LifeMD (LFMD) Debt to Equity (2016 - 2025)

LifeMD filings provide 6 years of Debt to Equity readings, the most recent being $5.31 for Q2 2025.

  • On a quarterly basis, Debt to Equity rose 258.5% to $5.31 in Q2 2025 year-over-year; TTM through Jun 2025 was $5.31, a 258.5% increase, with the full-year FY2024 number at -$1.12, changed N/A from a year prior.
  • Debt to Equity hit $5.31 in Q2 2025 for LifeMD, up from -$0.05 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $5.31 in Q2 2025 to a low of -$3.35 in Q2 2024.
  • Median Debt to Equity over the past 3 years was -$0.81 (2021), compared with a mean of -$0.04.
  • The widest YoY moves for Debt to Equity: up 258.5% in 2025, down 102.98% in 2025.
  • LifeMD's Debt to Equity stood at -$0.58 in 2021, then crashed by 92.78% to -$1.12 in 2024, then skyrocketed by 574.72% to $5.31 in 2025.
  • The last three reported values for Debt to Equity were $5.31 (Q2 2025), -$0.05 (Q1 2025), and -$1.12 (Q4 2024) per Business Quant data.